Literature DB >> 3652652

Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

V M Bieluch1, G J Cuchural, D R Snydman, S L Gorbach, F P Tally.   

Abstract

Resistance to cefoxitin among species of the Bacteroides fragilis group of organisms has remained low (8%-10%) in a multicenter nationwide survey. However, a statistically significant increase in the percentage of B. fragilis group organisms resistant to cefoxitin was found at Tufts-New England Medical Center from 1981 to 1982. Non fragilis species accounted for most of the resistance. The presence of cefoxitin resistance in B. fragilis isolates correlated with resistance to other antibiotics. The presence of cefoxitin-resistant B. fragilis group organisms also correlated with the presence of other cefoxitin-resistant bacteria. No difference could be detected in therapeutic outcome of patients with cefoxitin-sensitive or cefoxitin-resistant B. fragilis group organisms, regardless of treatment with cefoxitin or other antibiotics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652652     DOI: 10.1016/0732-8893(87)90029-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

Review 1.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

2.  Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

Authors:  J Gómez; V Baños; J Ruiz; F Herrero; M Pérez; L Pretel; M Canteras; M Valdés
Journal:  Clin Investig       Date:  1993-08

3.  Analysis of the Structure and Function of FOX-4 Cephamycinase.

Authors:  S T Lefurgy; V N Malashkevich; J T Aguilan; E Nieves; E C Mundorff; B Biju; M A Noel; R Toro; D Baiwir; K M Papp-Wallace; S C Almo; J-M Frere; G Bou; R A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.